Chongqing Zhifei Biological Products Co.Ltd(300122) : recombinant covid-19 vaccine zifivax was approved for emergency use in Colombia

Interface news was learned from Chongqing Zhifei Biological Products Co.Ltd(300122) that in January 22nd, a wholly owned subsidiary of Anhui, Zhi Fei Long Ma Ma, received a document on the approval of emergency use of the New Coronavirus vaccine (CHO cell) (Zifivax) in Columbia, according to the Columbia food and Drug Administration (INVIMA) 2022002030th resolution January 21, 2022. The New Coronavirus vaccine (CHO cell) (Zifivax) is officially granted emergency use license.